Literature DB >> 15567552

Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study.

Serpil Bulut1, M Said Berilgen, Aslihan Baran, Aslan Tekatas, Murad Atmaca, Bulent Mungen.   

Abstract

In patients with migraine with or without aura the prophylactic effect of amitriptyline (AMT) and venlafaxine (VLF) was compared in a randomized double-blind crossover study. Intolerable side effects resulted in drop out of five patients on AMT (due to hypersomnia, difficulty in concentration and orthostatic hypotension) and one patient on VLF (because of nausea and vomiting). Following the run-in period the patients (n = 52) were randomly treated with one of the study medications for 12 weeks. After a wash-out period lasting 4 weeks the patients were treated with the other drug for further 12 weeks. Both drugs had significant beneficial effect on pain parameters. Total number of side effects of VLF was low when compared with the side effect profile of AMT. In conclusion, it is suggested that VLF may be considered for the prophylaxis of migraine because of its low and/or tolerable side effect properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567552     DOI: 10.1016/j.clineuro.2004.03.004

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  27 in total

1.  Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application.

Authors:  Junhua Yu; Kenneth J Smith; Diana I Brixner
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 2.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.

Authors:  Caroline T Nguyen; Michael I MacEntee; Barbara Mintzes; Thomas L Perry
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

4.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

Review 5.  [Alternatives to beta blockers in preventive migraine treatment].

Authors:  S Evers
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

Review 6.  Prophylaxis of migraine headache.

Authors:  Tamara Pringsheim; W Jeptha Davenport; Werner J Becker
Journal:  CMAJ       Date:  2010-02-16       Impact factor: 8.262

Review 7.  Tricyclic antidepressants and headaches: systematic review and meta-analysis.

Authors:  Jeffrey L Jackson; William Shimeall; Laura Sessums; Kent J Dezee; Dorothy Becher; Margretta Diemer; Elizabeth Berbano; Patrick G O'Malley
Journal:  BMJ       Date:  2010-10-20

Review 8.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Headache and hormone replacement therapy in the postmenopausal woman.

Authors:  E Anne MacGregor
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

10.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.